Moderna Balance Sheet Health
Financial Health criteria checks 6/6
Moderna has a total shareholder equity of $11.7B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $15.7B and $4.0B respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$8.49b |
| Equity | US$11.71b |
| Total liabilities | US$3.97b |
| Total assets | US$15.68b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MRNA's short term assets ($9.7B) exceed its short term liabilities ($2.4B).
Long Term Liabilities: MRNA's short term assets ($9.7B) exceed its long term liabilities ($1.6B).
Debt to Equity History and Analysis
Debt Level: MRNA is debt free.
Reducing Debt: MRNA had no debt 5 years ago.
Debt Coverage: MRNA has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: MRNA has no debt, therefore coverage of interest payments is not a concern.